骨痹相关疾病“从肾论治”的实验研究进展  

The Progress of Experimental Study of the Theory "kidney-treating" of GUBI Related Diseases

作　　者：方剑利[1] 许兵[1] 童培建[2] 

机构地区：[1]浙江中医药大学,浙江杭州310053 [2]浙江省中医院,浙江杭州310053

出　　处：《中华中医药学刊》2011年第11期2448-2451,共4页Chinese Archives of Traditional Chinese Medicine

基　　金：国家自然科学基金资助项目(30873276)

摘　　要：骨痹的临床范畴包括退行性骨关节病、骨质疏松、骨坏死等。早在内经之中就有关于骨痹的记载。在中医药传统理论"肾主骨"理论指导下,多数医家对骨痹相关疾病主张"从肾论治",并取得了不错的临床效果。随着科学技术的发展进步,许多学者结合现代细胞分子生物学技术通过开展对补肾药物治疗骨痹相关疾病的实验研究,来阐明骨痹相关疾病"从肾论治"理论的现代含义,并取得了不错的进展,就近年来的研究现状做一综述。The clinical category of GuBi diseases includes degenerative joint disease,osteoporosis,osteonecrosis and etc.Huangdi Neijing have mentioned ＂GUBI＂ since thousands years ago.In the guidance of the theory of ＂ the kidney dominates bone＂,most doctors manifest treating the GUBI diseases should comply with the theory of＂treatment accord the kidney＂,and take a good clinical effect.With the development of science and technology progress,many scholars carried out the experiment research on the drug of tonifying kidney therapy of GuBi related diseases combining modern cells molecular biology technology,to clarify the modern sense of the theory ＂kidney-treating＂and made good progress in recent years.The research status in recent years were introduced in this paper.

关 键 词：骨痹 肾主骨 从肾论治 

分 类 号：R274[医药卫生—中医骨伤科学]